Man Collapses During Oval Office Announcement with President Trump
During a press conference in the Oval Office on Thursday, a man collapsed behind President Donald Trump amid an event focused on expanding coverage and reducing prices for obesity treatments Zepbound and Wegovy.
Officials quickly responded to the incident. As the man fainted, Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz supported his head while he was lowered to the floor. The cause of the collapse remains unclear.
White House press secretary Karoline Leavitt later informed reporters that the man was a guest representing one of the attending healthcare companies, Eli Lilly and Novo Nordisk.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
About an hour after the incident, President Trump resumed the event without the man, who did not return to the Oval Office. Trump mentioned the man was feeling lightheaded but was now fine.
President Trump announced a new agreement with drugmakers Eli Lilly and Novo Nordisk to broaden Medicare coverage and lower prices of the widely used obesity drugs.
Newsweek has requested further comments from the White House via email.
Summary: A representative fainted during President Trump's press event on obesity drug pricing, prompting medical aid and a brief pause before the announcement continued.